Medtronic (MDT) Climbs 5.7% on Stellar Q4

Medtronic PLC (NYSE:MDT) is one of the 10 Stocks With Remarkable Resilience.

Medtronic saw its share prices jump by 5.69 percent on Wednesday to finish at $77.95 apiece, as investors took heart from its strong earnings performance in the fourth quarter and full fiscal year 2026.

In an updated report, Medtronic PLC (NYSE:MDT) said that it grew its attributable net income for the fourth quarter of its fiscal year ending April by 17 percent to $1.243 billion from $1.057 billion in the same period last year.

Stealth AXiS surgical system. Photo from Medtronic

Net sales surged by 10 percent to $9.8 billion from $8.9 billion year-on-year, on the back of higher revenues from cardiovascular, neuroscience, medical surgical, and diabetes business portfolios.

For the full fiscal year, attributable net profit picked up by 2.98 percent to $4.8 billion from $4.66 billion, while net sales grew by 8.5 percent to $36.36 billion from $33.5 billion year-on-year.

In line with the strong results, Medtronic PLC (NYSE:MDT) has raised its revenue growth outlook for full fiscal 2027 to a range of 6.75 percent to 7.25 percent year-on-year.

“As we look to FY27, we are entering the year with strong momentum, a resilient operating foundation, and a clear path to deliver durable growth. With a uniquely robust pipeline, our tuck-in M&A and investment strategy activated, and continued financial discipline, we are poised to build on our FY26 performance,” Medtronic PLC (NYSE:MDT) CFO Thierry Piéton said.

The company also authorized the distribution of higher cash dividends, amounting to $0.72 versus $0.71 previously, translating to a total of $2.88 per share for the year.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.